CeriBell Inc
CBLL11.440USD
-0.420-3.54%
Fechamento 09/10, 16:00（ET）Cotações atrasadas em 15 min
418.70MValor de mercado
PerdaP/L TTM
Mais detalhes de CeriBell Inc Empresa
Ceribell, Inc. is a commercial-stage medical technology company. It is focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
Informações da empresa
Código da empresaCBLL
Nome da EmpresaCeribell Inc
Data de listagemOct 11, 2024
CEOMs. Xingjuan (Jane) Chao, Ph.D.
Número de funcionários281
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 11
Endereço360 N. Pastoria Avenue
CidadeSUNNYVALE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94085
Telefone18004360826
Sitehttps://ceribell.com/
Código da empresaCBLL
Data de listagemOct 11, 2024
CEOMs. Xingjuan (Jane) Chao, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.05M
-0.27%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
+4.31%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Brian Johnston
Brian Johnston
Investor Relations
Investor Relations
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Lucian Iancovici, M.D.
Dr. Lucian Iancovici, M.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.05M
-0.27%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
+4.31%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2023
FY2022
Por EmpresaUSD
Nome
Receita
Proporção
EEG recorders and EEG headbands, point in time
15.61M
76.17%
EEG portal and Clarity subscriptions, over time
4.88M
23.83%
Por RegiãoUSD
Nome
Receita
Proporção
United States
20.49M
100.00%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
EEG recorders and EEG headbands, point in time
15.61M
76.17%
EEG portal and Clarity subscriptions, over time
4.88M
23.83%
Distribuição de ações
Atualizado em: seg, 8 de set
Atualizado em: seg, 8 de set
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
12.79%
TPG Capital, L.P.
10.82%
Longitude Capital Management Co., LLC
6.75%
Ally Bridge Group (HK) Limited
6.66%
Global Value Investment Portfolio Management Pte. Ltd.
6.46%
Outro
56.52%
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
12.79%
TPG Capital, L.P.
10.82%
Longitude Capital Management Co., LLC
6.75%
Ally Bridge Group (HK) Limited
6.66%
Global Value Investment Portfolio Management Pte. Ltd.
6.46%
Outro
56.52%
Tipos de investidores
Investidores
Proporção
Investment Advisor
41.33%
Investment Advisor/Hedge Fund
18.68%
Private Equity
10.82%
Individual Investor
10.46%
Venture Capital
9.21%
Hedge Fund
2.82%
Research Firm
0.96%
Pension Fund
0.28%
Bank and Trust
0.19%
Outro
5.26%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
162
33.13M
90.36%
+3.75M
2025Q1
157
34.07M
94.45%
+6.99M
2024Q4
111
32.79M
91.42%
+9.94M
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Fidelity Management & Research Company LLC
4.75M
13.15%
-38.89K
-0.81%
Mar 31, 2025
TPG Capital, L.P.
3.97M
10.98%
--
--
Mar 31, 2025
Longitude Capital Management Co., LLC
2.48M
6.85%
+2.48M
--
Oct 16, 2024
Ally Bridge Group (HK) Limited
2.18M
6.02%
-134.10K
-5.80%
Apr 11, 2025
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.55%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
6.1%
--
--
Mar 31, 2025
Parvizi (Josef)
2.09M
5.78%
+6.62K
+0.32%
Apr 11, 2025
BlackRock Institutional Trust Company, N.A.
782.72K
2.17%
+78.31K
+11.12%
Mar 31, 2025
The Vanguard Group, Inc.
693.83K
1.92%
-2.26K
-0.32%
Mar 31, 2025
Chao (Xingjuan)
1.05M
2.92%
--
--
Jun 03, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de set
Atualizado em: sáb, 6 de set
Nome
Proporção
iShares Neuroscience and Healthcare ETF
0.55%
Hypatia Women CEO ETF
0.45%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Franklin US Small Cap Multifactor Index ETF
0%
FlexShares Morningstar US Market Factor Tilt Index Fund
0%
iShares Morningstar Small-Cap ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Neuroscience and Healthcare ETF
Proporção0.55%
Hypatia Women CEO ETF
Proporção0.45%
ProShares Hedge Replication ETF
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0.01%
Franklin US Small Cap Multifactor Index ETF
Proporção0%
FlexShares Morningstar US Market Factor Tilt Index Fund
Proporção0%
iShares Morningstar Small-Cap ETF
Proporção0%
iShares Russell 2000 Value ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
